• Hepatitis C Virus (HCV) by Molecular Method, Qualitative or Quantitative
  • Spinocerebellar Ataxia Type 3 (SCA3) (Machado-Joseph Disease) Gene Mutation Analysis
  • Prostate Specific Antigen (PSA), Total
  • Syphilis, tertiary
  • Platelet Count
  • Inhibin A and B, Tumor Marker
  • RET/PTC Gene Rearrangement, Molecular
  • Mantle cell lymphoma
  • Beta-amyloid (Aβ1-40 and Aβ1-42)
  • Porphobilinogen, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Phenosense Entry HIV Drug Resistance Assay
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Phenosense Entry HIV Drug Resistance Assay
Medical Test

Clinical Utility
Access to Phenosense Entry HIV Drug Resistance Assay is restricted.